171 related articles for article (PubMed ID: 30676931)
1. Predictors of Healthcare Effectiveness Data and Information Set (HEDIS) treatment initiation and engagement among patients with opioid use disorder across 7 health systems.
Campbell CI; Weisner C; Binswanger IA; Lapham GT; Ahmedani BK; Yarborough BJH; Haller IV; Altschuler A; Hechter RC; Loree AM; Kline-Simon AH
Subst Abus; 2019; 40(3):328-334. PubMed ID: 30676931
[No Abstract] [Full Text] [Related]
2. Patient characteristics associated with treatment initiation and engagement among individuals diagnosed with alcohol and other drug use disorders in emergency department and primary care settings.
Kline-Simon AH; Stumbo SP; Campbell CI; Binswanger IA; Weisner C; Haller IV; Hechter RC; Ahmedani BK; Lapham GT; Loree AM; Sterling SA; Yarborough BJH
Subst Abus; 2019; 40(3):278-284. PubMed ID: 30702983
[No Abstract] [Full Text] [Related]
3. The prevalence of Healthcare Effectiveness Data and Information Set (HEDIS) initiation and engagement in treatment among patients with cannabis use disorders in 7 US health systems.
Lapham GT; Campbell CI; Yarborough BJH; Hechter RC; Ahmedani BK; Haller IV; Kline-Simon AH; Satre DD; Loree AM; Weisner C; Binswanger IA
Subst Abus; 2019; 40(3):268-277. PubMed ID: 30657438
[No Abstract] [Full Text] [Related]
4. Psychiatric comorbidity and Healthcare Effectiveness Data and Information Set (HEDIS) measures of alcohol and other drug treatment initiation and engagement across 7 health care systems.
Loree AM; Yeh HH; Satre DD; Kline-Simon AH; Yarborough BJH; Haller IV; Campbell CI; Lapham GT; Hechter RC; Binswanger IA; Weisner C; Ahmedani BK
Subst Abus; 2019; 40(3):311-317. PubMed ID: 30681938
[No Abstract] [Full Text] [Related]
5. The association between medical comorbidity and Healthcare Effectiveness Data and Information Set (HEDIS) measures of treatment initiation and engagement for alcohol and other drug use disorders.
Binswanger IA; Carroll NM; Ahmedani BK; Campbell CI; Haller IV; Hechter RC; McNeely J; Yarborough BJH; Kline-Simon AH; Satre DD; Weisner C; Lapham GT
Subst Abus; 2019; 40(3):292-301. PubMed ID: 30676892
[No Abstract] [Full Text] [Related]
6. Factors associated with Healthcare Effectiveness Data and Information Set (HEDIS) alcohol and other drug measure performance in 2014-2015.
Weisner C; Campbell CI; Altschuler A; Yarborough BJH; Lapham GT; Binswanger IA; Hechter RC; Ahmedani BK; Haller IV; Sterling SA; McCarty D; Satre DD; Kline-Simon AH
Subst Abus; 2019; 40(3):318-327. PubMed ID: 30676915
[No Abstract] [Full Text] [Related]
7. Healthcare Effectiveness Data and Information Set (HEDIS) measures of alcohol and drug treatment initiation and engagement among people living with the human immunodeficiency virus (HIV) and patients without an HIV diagnosis.
Hechter RC; Horberg MA; Weisner C; Campbell CI; Contreras R; Chen LH; Yarborough BJH; Lapham GT; Haller IV; Ahmedani BK; Binswanger IA; Kline-Simon AH; Satre DD
Subst Abus; 2019; 40(3):302-310. PubMed ID: 30908174
[No Abstract] [Full Text] [Related]
8. Correlates of specialty substance use treatment among adults with opioid use disorders.
Romo E; Ulbricht CM; Clark RE; Lapane KL
Addict Behav; 2018 Nov; 86():96-103. PubMed ID: 29551551
[TBL] [Abstract][Full Text] [Related]
9. Patient and System Characteristics Associated with Performance on the HEDIS Measures of Alcohol and Other Drug Treatment Initiation and Engagement.
Yarborough BJH; Chi FW; Green CA; Hinman A; Mertens J; Beck A; Horberg M; Weisner C; Campbell CI
J Addict Med; 2018; 12(4):278-286. PubMed ID: 29557802
[TBL] [Abstract][Full Text] [Related]
10. Predictors of substance use treatment initiation and engagement among adult and adolescent Medicaid recipients.
Lind BK; McCarty D; Gu Y; Baker R; John McConnell K
Subst Abus; 2019; 40(3):285-291. PubMed ID: 30759050
[No Abstract] [Full Text] [Related]
11. Prevalence and treatment of opioid use disorders among primary care patients in six health systems.
Lapham G; Boudreau DM; Johnson EA; Bobb JF; Matthews AG; McCormack J; Liu D; Samet JH; Saxon AJ; Campbell CI; Glass JE; Rossom RC; Murphy MT; Binswanger IA; Yarborough BJH; Bradley KA;
Drug Alcohol Depend; 2020 Feb; 207():107732. PubMed ID: 31835068
[TBL] [Abstract][Full Text] [Related]
12. Maternal and infant characteristics associated with maternal opioid overdose in the year following delivery.
Nielsen T; Bernson D; Terplan M; Wakeman SE; Yule AM; Mehta PK; Bharel M; Diop H; Taveras EM; Wilens TE; Schiff DM
Addiction; 2020 Feb; 115(2):291-301. PubMed ID: 31692133
[TBL] [Abstract][Full Text] [Related]
13. Adults who misuse opioids: Substance abuse treatment use and perceived treatment need.
Choi NG; DiNitto DM; Marti CN; Choi BY
Subst Abus; 2019; 40(2):247-255. PubMed ID: 30810503
[No Abstract] [Full Text] [Related]
14. Age differences in emergency department utilization and repeat visits among patients with opioid use disorder at an urban safety-net hospital: A focus on young adults.
Choi S; Biello KB; Bazzi AR; Drainoni ML
Drug Alcohol Depend; 2019 Jul; 200():14-18. PubMed ID: 31071494
[TBL] [Abstract][Full Text] [Related]
15. Multimorbidity and Inpatient Utilization Among Older Adults with Opioid Use Disorder in New York City.
Han BH; Tuazon E; Y Wei M; Paone D
J Gen Intern Med; 2022 May; 37(7):1634-1640. PubMed ID: 34643872
[TBL] [Abstract][Full Text] [Related]
16. The importance of identification when measuring performance in addiction treatment.
Garnick D; Horgan C; Mark TL; Lee M; Acevedo A; Neager S; O'Brien P; Hashmi A; Marder B; Miller K
Subst Abus; 2019; 40(3):263-267. PubMed ID: 30913002
[No Abstract] [Full Text] [Related]
17. Developing a clinical decision support for opioid use disorders: a NIDA center for the clinical trials network working group report.
Bart GB; Saxon A; Fiellin DA; McNeely J; Muench JP; Shanahan CW; Huntley K; Gore-Langton RE
Addict Sci Clin Pract; 2020 Jan; 15(1):4. PubMed ID: 31948487
[TBL] [Abstract][Full Text] [Related]
18. Timing of treatment for opioid use disorder among birthing people.
Kim K; Liu G; Dick AW; Choi SW; Agbese E; Corr TE; Hsuan C; Wright MS; Park S; Velott D; Leslie DL
J Subst Use Addict Treat; 2024 Jun; 161():209289. PubMed ID: 38272119
[TBL] [Abstract][Full Text] [Related]
19. Age of initiation, psychopathology, and other substance use are associated with time to use disorder diagnosis in persons using opioids nonmedically.
Schepis TS; Hakes JK
Subst Abus; 2017; 38(4):407-413. PubMed ID: 28723266
[TBL] [Abstract][Full Text] [Related]
20. The quality of quality measures: HEDIS® quality measures for medication management in the elderly and outcomes associated with new exposure.
Pugh MJ; Marcum ZA; Copeland LA; Mortensen EM; Zeber JE; Noël PH; Berlowitz DR; Downs JR; Good CB; Alvarez C; Amuan ME; Hanlon JT
Drugs Aging; 2013 Aug; 30(8):645-54. PubMed ID: 23645530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
